Tag: Cancer Research UK

September 30, 2019 Off

Elevar Therapeutic’s rivoceranib trial has potential to treat late-stage gastric cancer patients, study says

Elevar Therapeutics presented a study at ESMO, showing the potential of rivoceranib to treat patients with late-stage gastric cancer, which was is the first multinational phase 3 study after rivoceranib’s approval in China, said Dr. Steven Norton, Elevar Therapeutics’ Vice President of Clinical Development.

February 10, 2017 Off

U.S. scientists get $87 million Grand Challenge awards to quicken battle against cancer

By Dino Mustafić

Cancer Research UK (CR UK), the world’s largest not-for-profit cancer research organization, has today announced that six leading U.S. scientists are among the winners of a global competition to help overcome the biggest challenges facing cancer research.